Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tirzepatide met both co-primary endpoints during the 72-week double-blind treatment period, demonstrating the superiority of the drug over placebo
Research Use Only Not for human consumption or medical applications
This benefit is also supported by trials such as LEADER, SUSTAIN-6, and EXSCEL, in which the reduction in MACE was significant among those with established ASCVD
Some Anthem plans cover this indication when they exclude "weight loss." See our complete OSA coverage guide Other options if coverage isn't available: Self-pay via LillyDirect: Single-dose vials at $299/month (2.5mg) to $449/month (higher doses)prices reduced in late 2025 [11] Zepbound Cost Guide TrumpRx.gov: ~$346/month for Zepbound (launched Feb 5, 2026) [15] Foundayo: Eli Lilly's oral GLP-1 tablet (FDA approved April 1, 2026)no injections, may have different coverage Compare medications: Wegovy, Mounjaro & more Alternatives Guide Switch plans: Check other insurers during open enrollment WHAT'S CHANGING 2026 Outlook Major developments are reshaping GLP-1 access in 2026
